Protecting kids’ skin from the sun is a priority that extends beyond the summer holidays. According to NHS guidance, children ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a ...

The FDA pushed back the Prescription Drug User Fee Act action date for ruxolitinib cream (Opzelura) by three months to September 19, 2025. The extension will allow regulators time to review additional ...

Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the ...

This week brings the launch of a fresh pair of Bowers & Wilkins headphones, a new kids collection from Calpak and a ...

You know how it goes. You look amazing when no one's around, but the second you need to leave the house, your skin has a ...

Discover life-changing eczema treatments and remedies that provide real relief. From prescription breakthroughs to natural ...

Medically reviewed by William Truswell, MD Eczema is a long-term condition where an overactive immune response causes skin inflammation (swelling) and irritation. Eczema leads to dry, itchy patches of ...

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.

An irritating skin condition is flaring up for a third of Australians trying to keep warm this winter, made worse by heaters, ...